Press & Events
Congratulations to our SAB member Dr. Shinya Yamanaka for winning the Nobel Prize in Medicine
iPierian Advances Monoclonal Antibody Drug Development Programs Targeting Tau Protein and the Complement System for the Treatment of Neurodegenerative Diseases
iPierian Appoints Pamela B. Conley as Vice President of Research
iPierian Advances Monoclonal Antibody Drug Development Programs Targeting Tau Protein and the Complement System for the Treatment of Neurodegenerative Diseases
iPierian appoints Nancy Stagliano as CEO. Peter Van Vlasselaer, Interim CEO, becomes Executive Chairman of the Board
Kyoto University, iPS Academia Japan, and iPierian Announce Global Licensing and Patent Assignment Agreement
iPierian Expands Leadership Team With Experienced Business Development and Intellectual Property Executives
iPierian Closes $22 Million Series B Financing
iPierian Appoints Dr. Michael Venuti as President and Chief Scientific Officer
First iPierian Patent for Induced Pluripotent Stem Cell Technology Granted by United Kingdom Intellectual Property Office
Archived Press
2013
AprilMarch
February
January
2012
DecemberNovember
October
September
August
July
June
May
April
March
February
January